130 related articles for article (PubMed ID: 28229437)
41. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
[TBL] [Abstract][Full Text] [Related]
42. Imaging of monoamine oxidase-A in the human brain with [11C]befloxatone: quantification strategies and correlation with mRNA transcription maps.
Zanotti-Fregonara P; Leroy C; Rizzo G; Roumenov D; Trichard C; Martinot JL; Bottlaender M
Nucl Med Commun; 2014 Dec; 35(12):1254-61. PubMed ID: 25185897
[TBL] [Abstract][Full Text] [Related]
43. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with ¹⁸F-FE-PE2I.
Ikoma Y; Sasaki T; Kimura Y; Seki C; Okubo Y; Suhara T; Ito H
Ann Nucl Med; 2015 Oct; 29(8):697-708. PubMed ID: 26134215
[TBL] [Abstract][Full Text] [Related]
45. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients.
Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
J Cereb Blood Flow Metab; 2015 May; 35(5):766-72. PubMed ID: 25649991
[TBL] [Abstract][Full Text] [Related]
46. In vivo evaluation of [
Zhou X; Khanapur S; de Jong JR; Willemsen AT; Dierckx RA; Elsinga PH; de Vries EF
J Cereb Blood Flow Metab; 2017 Feb; 37(2):577-589. PubMed ID: 26917190
[TBL] [Abstract][Full Text] [Related]
47. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ
J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetic Analysis of 11C-PBR28 in the Rat Model of Herpes Encephalitis: Comparison with (R)-11C-PK11195.
Parente A; Feltes PK; Vállez García D; Sijbesma JW; Moriguchi Jeckel CM; Dierckx RA; de Vries EF; Doorduin J
J Nucl Med; 2016 May; 57(5):785-91. PubMed ID: 26823567
[TBL] [Abstract][Full Text] [Related]
49. Modeling alternatives for cerebral carbon-11-iomazenil kinetics.
Buck A; Westera G; vonSchulthess GK; Burger C
J Nucl Med; 1996 Apr; 37(4):699-705. PubMed ID: 8691270
[TBL] [Abstract][Full Text] [Related]
50. In Vivo Evaluation of Blood Based and Reference Tissue Based PET Quantifications of [11C]DASB in the Canine Brain.
Van Laeken N; Taylor O; Polis I; Neyt S; Kersemans K; Dobbeleir A; Saunders J; Goethals I; Peremans K; De Vos F
PLoS One; 2016; 11(2):e0148943. PubMed ID: 26859850
[TBL] [Abstract][Full Text] [Related]
51. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
[TBL] [Abstract][Full Text] [Related]
52. Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging.
Barret O; Mazère J; Seibyl J; Allard M
J Cereb Blood Flow Metab; 2008 Sep; 28(9):1624-34. PubMed ID: 18506194
[TBL] [Abstract][Full Text] [Related]
53. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A
J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters.
Millet P; Graf C; Buck A; Walder B; Ibáñez V
Neuroimage; 2002 Oct; 17(2):928-42. PubMed ID: 12377167
[TBL] [Abstract][Full Text] [Related]
55. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
[TBL] [Abstract][Full Text] [Related]
56. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
[TBL] [Abstract][Full Text] [Related]
57. Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.
Delforge J; Pappata S; Millet P; Samson Y; Bendriem B; Jobert A; Crouzel C; Syrota A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):284-300. PubMed ID: 7860662
[TBL] [Abstract][Full Text] [Related]
58. Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.
Syvänen S; Labots M; Tagawa Y; Eriksson J; Windhorst AD; Lammertsma AA; de Lange EC; Voskuyl RA
J Nucl Med; 2012 Dec; 53(12):1974-83. PubMed ID: 23143088
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetic Evaluation of the Tau PET Radiotracer
Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
[No Abstract] [Full Text] [Related]
60. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
